This article was written by Follow An individual investor primarily focused on undercovered companies, with more than 50 companies on my watchlist. My areas...
This article was written by Follow I look at small to mid-cap companies with disruptive technology. I provide competitive analysis of companies and often...
Using a digital advertising strategy is now largely the default option for most organizations, outside of a few very niche markets. The benefits offered...
Sarepta Therapeutics (NASDAQ:SRPT) is a large (~$14 billion market cap) biopharmaceutical company that markets 3 RNA-targeted products for Duchenne muscular dystrophy (DMD) patients. In...
How can the debt ceiling bind? As I discussed in an earlier Forbes article, the deficit is the annual difference between Federal government spending...